MedTrace Logo

Relaxation Treatment for Anxiety in Adults Aged 60 or Older

NCT02429778 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-01-27

Study results available
· View outcomes & findings →

Summary

The PI developed a self-directed program to treat late-life anxiety called Breathing, Relaxation, and Education for Anxiety Treatment in the Home Environment (BREATHE). This program consists of weekly video lessons that participants watch on digital video disc (DVD) along with weekly telephone check-ins. In BREATHE participants will learn two behavioral interventions: diaphragmatic breathing and progressive muscle relaxation (PMR). The purpose of the study is to examine whether the self-directed BREATHE program is superior to a wait list control in reducing anxiety in older adults with anxiety disorders. For those assigned to wait list control, they will be offered opportunity to participate in BREATHE treatment after 8 weeks of wait list.

Conditions

  • Anxiety Disorders

Interventions

BEHAVIORAL

Diaphragmatic Breathing

Deep or diaphragmatic breathing is taught prior to relaxation.

BEHAVIORAL

Progressive Muscle Relaxation

Tensing and releasing muscle groups in a specified order to help reduce tension and anxiety.

Sponsors & Collaborators

  • VA Palo Alto Health Care System

    collaborator FED

  • Brain & Behavior Research Foundation

    collaborator OTHER

  • Palo Alto Veterans Institute for Research

    lead OTHER

Principal Investigators

  • Christine E Gould, PhD · VA Palo Alto/Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02429778 on ClinicalTrials.gov